Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Injectable Drug Delivery Devices Market?
The market encompassing injectable drug delivery systems has exhibited robust expansion over the preceding years, with projections indicating a rise from USD 49.59 billion in 2024 to USD 54.3 billion by 2025, reflecting a compound annual growth rate of 9.5 percent; this ascending trajectory during the past period is underpinned by several key factors, notably the accelerated aging of the global population, an increase in the availability of medical institutions, escalating health expenditure, the surge in biologic drug development and usage, alongside greater public understanding of self-administered treatments.
Projections indicate robust expansion within the sector for injectable drug delivery apparatus, anticipating a market valuation reaching $73.85 billion by 2029, expanding at an 8.0 percent compounded annual growth rate across the forthcoming period; this upward trajectory is fueled by the rising incidence of long-term ailments, the surging requirement for pharmaceuticals administered via injection, the abrupt onset of serious contagions, and the substantial pipeline of medications and inoculations currently undergoing diverse phases of clinical evaluation. Key developments shaping this market involve a pronounced emphasis on creating drug conveyance mechanisms utilizing microneedles, intensified capital outlay towards innovating self-administering apparatus, concentrating on the fabrication of body-worn devices, prioritizing the production of systems that bypass traditional needles, broadening product portfolios to encompass pre-filled syringes, a drive to incorporate enhanced digital capabilities into existing equipment, and strategic efforts aimed at producing novel delivery implements, particularly auto-injectors.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp
What Are The Main Drivers Boosting The Injectable Drug Delivery Devices Industry’s Expansion?
A growing inclination towards utilizing self-injection mechanisms is fueling the expansion of the market for injectable drug delivery systems. These self-injection apparatuses, which permit individuals to administer their own prescribed medications in a domestic environment, encompass various types such as pen, auto, wearable, and needle-free injectors. Engineered for optimal user-friendliness and high accuracy in dispensing pharmaceuticals, these self-injectables have seen heightened adoption recently due to ongoing technological advancements in their design. BD Physioject, a product from Becton, Dickinson, and Company, stands out as a dependable, economically viable, disposable auto-injector, specifically tailored to enable patients managing long-term conditions like multiple sclerosis, rheumatoid arthritis, osteoporosis, and asthma, to inject their treatments independently. Key industry players operating within the self-injections sphere presently comprise Pfizer Inc., 3M, Baxter, AbbVie, Inc., Gerresheimer AG, among others. Driven by the inherent benefits associated with self-injectable administration methods and heightened consumer knowledge concerning at-home self-management, the need for these devices is set to escalate, propelling the injectable drug delivery devices sector throughout the projected timeframe.
What Are The Key Segments In The Injectable Drug Delivery Devices Market?
The injectable drug delivery devicesmarket covered in this report is segmented –
1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps
What Are The Major Trends Driving The Growth Of The Injectable Drug Delivery Devices Market?
Manufacturers specializing in injectable drug administration technologies are increasingly prioritizing the production of auto-injectors, which represent sophisticated, fully automated, and adaptable instruments allowing individuals to administer potentially hundreds of doses independently. These systems grant users command over the rate at which the medication is delivered, a feature designed to lessen any associated pain or distress during the injection process, as the devices are capable of regulating both the velocity and penetration depth of the automatic delivery. As an illustration, Unilife Corporation’s LISA reusable auto-injector boasts a suite of highly configurable options such as integrated Bluetooth Low Energy, Wi-Fi or 3G connectivity capabilities, and pre-injection technology to warm the drug substance for specific treatments. Significant expansion is projected for the injectable drug delivery sector overall in the subsequent period, driven by ongoing technological breakthroughs and the introduction of novel products aimed at enhancing the user-friendliness and simplicity of administering therapies parenterally.
Which Leading Players Are Enhancing Their Injectable Drug Delivery Devices Market Presence Worldwide?
Major companies operating in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Injectable Drug Delivery Devices Industry?
North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Injectable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2835&type=smp
Browse Through More Reports Similar to the Global Injectable Drug Delivery Devices Market 2025, By The Business Research Company
Implantable Drug Delivery Devices Global Market Report 2025
Drug Delivery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Liposomal Drug Delivery Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model